Liquid GPS® Successfully Launched in Q2 Total Revenue in Q2 was $22.0 Million Revenue in 2017 Q2 included a large completed...
CULVER CITY, Calif.–(BUSINESS WIRE)–Aug. 3, 2018– NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report...
Further Enhancing NaviNet’s Ability to Tackle Payer-Provider Communication Challenges June 20, 2018 03:24 PM Eastern Daylight Time LOS ANGELES-NantHealth, Inc....
Culver City, California and San Diego – June 19, 2018 – NantHealth (NASDAQ: NH), a next-generation healthcare company, will exhibit and present...
7:02 pm MST | Jun 8, 2018 | BioCentury | Product Development POC FOR CYTOKINES Cytokines are emerging as a...
Soon-Shiong offers insights on research and development efforts, clinical update during presentation in New York. NEW YORK CITY, June 7...
Results to be presented during the tumor biology session at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting...
Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 4,...
Molecular test allows for continuous, noninvasive monitoring and tumor profiling CHICAGO— June 2, 2018 – NantHealth, Inc., (NASDAQ: NH), a...
Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 4,...
CULVER CITY, Calif.–(BUSINESS WIRE)–May 30, 2018– NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that its...
Culver City, Calif. – May 16, 2018 — NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced...